The involvement of the changed expression/function of neurotrophic factors in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD), has been …
L Wang, XX Li, X Chen, XY Qin, E Kardami… - Frontiers in molecular …, 2018 - frontiersin.org
The occurrence of depressive disorder has long been attributed to changes in monoamines, with the focus of drug treatment strategies being to change the effectiveness of monoamines …
A Tennakoon, V Katharesan… - Journal of …, 2022 - Wiley Online Library
The role of increased brain inflammation in the development of neurodegenerative diseases is unclear. Here, we have compared cytokine changes in normal aging, motor neurone …
O Even-Chen, S Barak - Journal of Neuroscience, 2019 - Soc Neuroscience
Excessive alcohol intake leads to mesostriatal neuroadaptations, and to addiction phenotypes. We recently found in rodents that alcohol increases fibroblast growth factor 2 …
S Yuan, H Li, C Yang, W Xie, Y Wang, J Zhang… - Biomedicine & …, 2020 - Elsevier
Monocytes play a crucial role in Alzheimer's disease (AD), and docosahexaenoic acid (DHA) has a neuroprotective effect for many neurodegenerative diseases. However …
Astrocytes are the most abundant type of glial cells in the brain, and they play a key role in Alzheimer's disease (AD). Fibroblast Growth Factor-2 (FGF-2) has been implicated as a …
L Xiao, X Yang, YP Loh - Frontiers in Neuroscience, 2019 - frontiersin.org
Carboxypeptidase E, also known as neurotrophic factor-α1 (CPE-NFα1), was first discovered as an exopeptidase and is known to work by cleaving C-terminal basic amino …
ZP Cai, C Cao, Z Guo, Y Yu, SJ Zhong, RY Pan… - Heliyon, 2021 - cell.com
We previously demonstrated the antioxidant activity of Coeloglossum viride var. bracteatum extract (CE) in rat cortical neurons and in mice with chemically induced cognitive …
Objectives This study compared the immune‐related secretory capacity of human vestibular schwannoma (VS) and tumor‐assisted macrophages (TAMs) with their normal counterparts …